Date Filed | Type | Description |
08/31/2017 |
4
| Grant Stuart (EVP and CFO) has filed a Form 4 on Patheon N.V.
Txns:
| Disposed of 196,485 shares
@ $0 Unknown transaction of 566,603 shares
@ $35, valued at
$19.8M
|
|
07/22/2016 |
4
| Grant Stuart (EVP and CFO) has filed a Form 4 on Patheon N.V. |
07/20/2016 |
3
| Grant Stuart (EVP and CFO) has filed a Form 3 on Patheon N.V. |
03/12/2014 |
4
| Grant Stuart (CFO) has filed a Form 4 on PATHEON INC
Txns:
| Disposed/sold 393,000 options to buy
@ $7.65, valued at
$3M
Disposed/sold 125,000 options to buy
@ $7.47, valued at
$933.8k
|
|
06/20/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/15/2012 |
4
| Grant Stuart (CFO) has filed a Form 4 on PATHEON INC
Txns:
| Granted 425,000 options to buy
@ $0 |
|
03/05/2012 |
3
| Grant Stuart (CFO) has filed a Form 3 on PATHEON INC |
08/06/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/04/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/05/2010 |
4
| Grant Stuart (SR VP & CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns:
| Sold 1,250 shares
@ $7.68, valued at
$9.6k
Exercised 1,250 options to buy
@ $1.2, valued at
$1.5k
|
|
04/30/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
04/14/2010 |
4
| Grant Stuart (SR VP & CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns:
| Sold 509 shares
@ $8.26, valued at
$4.2k
Exercised 509 options to buy
@ $3.26, valued at
$1.7k
|
|
04/06/2010 |
4
| Grant Stuart (SR VP & CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns:
| Sold 1,236 shares
@ $6.96, valued at
$8.6k
Sold 13 shares
@ $6.97, valued at
$90.6 Exercised 1,249 options to buy
@ $1.2, valued at
$1.5k
|
|
03/04/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/25/2010 |
4
| Grant Stuart (SR VP & CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns:
| Sold 17,027 shares
@ $7.02, valued at
$119.5k
|
|
01/05/2010 |
4
| Grant Stuart (SR VP & CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns:
| Paid exercise price by delivering 7,812 shares
@ $6.46, valued at
$50.5k
|
|
03/04/2009 |
4
| Grant Stuart (SR VP & CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC |
02/03/2009 |
4
| Grant Stuart (SR VP & CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC |